arrow
C

Chengappa Kavadichanda

clinical immunology and rheumatology and rheumacare
H指数:18
被引数:1,301

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic implications and correlates of plasma ADA2 activity and ADA2 variants

血浆ADA2活性的诊断意义及相关因素与ADA2变异体

2025-10-280
OAAI
Remission and low disease activity definitions in adult idiopathic inflammatory myopathies: A narrative review by myositis clinical trials consortium (MCTC)

成人特发性炎症性肌病中的缓解和低疾病活动度定义:肌炎临床研究联盟(MCTC)的综述

2025-07-140
PRE
Cancer risk and screening effectiveness in idiopathic inflammatory myopathy: validating IMACS guidelines in a retrospective Indian cohort

癌症风险和筛查有效性在特发性炎症性肌病中的应用:验证IMACS指南在一项回顾性印度队列研究中的适用性

2025-04-280
PRE
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis

印度风湿病协会ANCA相关血管炎管理指南

2024-11-010
PRE
ASSESSMENT OF CLINICAL OUTCOMES AND PREDICTIVE FACTORS IN DIFFICULT-TO-TREAT LUPUS NEPHRITIS: A COMPREHENSIVE RETROSPECTIVE COHORT STUDY FROM A TERTIARY CARE CENTER

评估难治性狼疮肾炎的临床结局及预测因素:一项来自三级医疗中心的全面回顾性队列研究

2024-06-010
PRE
LONG TERM SAFETY OUTCOMES AND PREDICTORS OF SERIOUS INFECTIONS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH RITUXIMAB: OBSERVATIONS FROM A SINGLE CENTER BIOLOGIC REGISTRY

系统性红斑狼疮患者接受利妥昔单抗治疗后的长期安全性结局及严重感染预测因素:单中心生物制剂登记研究的观察结果

2024-06-010
PRE
Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE)
2023-12-122
PRE